ABC | Volume 114, Nº5, May 2020

Viewpoint Costa et al. Cardiovascular Implication of Covid-19 Arq Bras Cardiol. 2020; 114(5):834-838 29. Glasser JW,HupertN,McCauleyMM,HatchettR.Modelingandpublichealth emergencyresponses: lessons fromSARS.Epidemics.2011;3(1):32-7. 30. ZhangJJ,DongX,CaoYY,YuanYD,YangYB,YanYQ,etal.Clinicalcharacteristics of 140 patients infected with SARS-CoV-2 inWuhan, China. Allergy. 2020 Feb 19. [Epubaheadofprint]. 31. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. 32. KuikenT,FouchierRAM,SchuttenM,RimmelzwaanGF,vanAmerongenG,van RielD,etal.Newlydiscoveredcoronavirusastheprimarycauseofsevereacute respiratorysyndrome.Lancet.2003;362(9380):263–70. 33. Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses:frommechanismstopotentialtherapeutictools.Virol.Sin .2020Mar 3. [Epubaheadofprint]. 34. Guimarães HP, Damasceno MC, Braga MA, Schubert DUC, Santana JCB, Freitas APR, et al. Coronavírus e medicina de emergência: recomendações para o atendimento inicial do médico emergencista pela Associação Brasileira de Medicina de Emergência (ABRAMEDE). [citado 23 mar. 2020]. Disponível em: https://www.amib.org . br/fileadmin/user_upload/POSICIONAMENTO_ABRAMEDE_-_ CORONAVIRUS_-_03-__10032020.pdf. 35. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 Mar 11. [Epub ahead of print]. 36. Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID -19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020:41(2):145-51. This is an open-access article distributed under the terms of the Creative Commons Attribution License 838